Background: Some studies have developed scores for the assessment of surgical risk, particularly the EuroSCORE, which, however, is complex and difficult to apply. We suggest a new and simpler score, which is more appropriate for the clinical practice and for the assessment of surgical risk in patients with heart valve diseases.
Three phases are recognized in the natural history of patients with heart valve diseases: asymptomatic, symptomatic, and "transition phase", which is usually difficult to identify. Several adaptive changes such as cardiac chamber hypertrophy and dilatation occur, and advanced disease markers such as pulmonary hypertension and atrial fibrillation develop.
The onset of symptoms is an evidence for surgical indication 4 , but the extent to which preoperative symptoms have a negative influence on postoperative survival remains controversial 5, 6 . Some studies 6, 7 , however, have demonstrated that the indication of surgery in minimally symptomatic selected patients may be beneficial. In this group, we point out the importance of surgery for patients with heart valve disease accompanied by left ventricular dysfunction 7, 8 . Other studies [9] [10] [11] used some parameters to evaluate the surgical risk in heart disease populations. EuroSCORE 12, 13 is an excellent tool for the evaluation of cardiac surgery risk. However, this score was validated in an older population with a very low incidence of rheumatic disease, in addition to not being specific for heart valve surgery.
In view of these facts, we created a simplified score based on four critical situations for heart valve disease patients,
Introduction
Recently, some studies have demonstrated changes in the management of patients with heart valve disease. One of them showed an association between aortic valve sclerosis and cardiovascular mortality and morbidity, even in asymptomatic patients 1 . In asymptomatic mitral regurgitation 2 , an effective regurgitant orifice of at least 40 mm 2 is a good predictor of clinical outcome in the medical follow-up. However, it is difficult to define the best moment for indication of surgery in patients with heart valve disease and to predict surgical mortality and morbidity.
Rheumatic valve diseases are still common in developing countries 3 . For this reason, many patients undergo surgery very early in life 4 , and frequently require reoperations during the natural history of the disease. named VMCP. Thus, the VMCP score (V [heart valve lesion], M [myocardial function], C [coronary artery disease], and P [pulmonary artery pressure]) was used to identify patients with more severe preoperative disease and to correlate postoperative mortality and morbidity with heart valve surgery.
Methods
Medical records of 927 consecutive patients undergoing heart valve surgery in our Institution were analyzed. A total of 159 patients were excluded due to incomplete data, resulting in a final sample of 768 patients. Data collection from the medical records was conducted retrospectively, and the study protocol was approved by the institutional human research committee.
The mean age of this cohort was 50±17 years, 55% of the patients were women, 60% had rheumatic heart disease and 38% of the surgeries were reoperations. All patient demographics and clinical data are shown in Table 1 . Surgical mortality and morbidity, as well as the presence of comorbidities and in-hospital parameters were analyzed. The parameters studied included length of hospital stay (LHS), length of ICU stay, duration of extracorporeal circulation, surgical procedure report, emergency surgery, reoperation, and pre and postoperative complications.
Mortality was defined as intraoperative patient death or death during hospital stay. Morbidity was defined based on the mean length of hospital stay in our institution (10 days) and was considered as a length of hospital stay longer than 10 days.
The following preoperative comorbidities were studied: �ypertension (defined as blood pressure �� �40/90 mmHg)�� diabetes (fasting plasma glucose �� ���� mg/dl)�� r�eumatic fever, cigarette smoking (yes or no, and the amount of cigarettes smoked per day), dyslipidemia (total cholesterol > 240 mg/dl and LDL > 160 mg/dl), renal failure (creatinine > 2 mg/dl), heart failure, stroke and atrial fibrillation.
With the purpose of creating a simple and practical index -the VMCP score and index -four parameters considered fundamental to characterize heart valve disease were used ( Table 2) Each of these parameters was classified into four categories, and the sum of the points of the four index parameters, for instance, V3M2C2P2, result in the score 9 (3+2+2+2).
The criteria used for the classification of each variable included clinical and laboratory parameters used in the routine assessment of patients with heart valve disease. Variable V was based on history, clinical examination (presence of symptoms and cardiac auscultation) and echocardiographic diagnosis (single or multiple heart valve lesions). For the definition of mild, moderate or severe heart valve lesion, the criteria described in the guidelines for heart valve disease of the American Heart Association/American College of Cardiology 14 were used. Thus, for instance, mitral stenosis was considered mild if the valve area was greater than 1.5 cm 2 . Mild lesions, provided that multivalvular and that the patient was symptomatic, were also classified as V4. As regards the presence of symptoms, we considered parameters going from dyspnea (functional class I to IV) to angina and signs of low output such as syncope. Variable M analyzed myocardial function as assessed by left ventricular ejection fraction and echocardiographically quantified using the Teichholz method. Variable C analyzed the coronary circulation based on coronary angiography. Finally, variable P used the pulmonary artery pressure to evaluate the presence and degree of pulmonary hypertension, as indirectly assessed by right ventricular systolic pressure and quantified by tricuspid regurgitation observed on echocardiography.
Statistical analysis
The statistical analysis was carried out using the SPSS for Windows software (version 13.0). Data on continuous variables were analyzed using the t test and data on categorical variables were analyzed using the chi-square test. Continuous variables were expressed as mean ± standard deviation (SD), and categorical variables as a number (percentage, %). P values < 0.05 were considered statistically significant. Internal score consistency was assessed using alpha (Cronbach) and the area under the curve was estimated. The mean length of hospital stay in our institution (10 days) was used to define the cut-off point of the score.
ROC curves were used to define the most appropriate cut-off values for the score to predict length of hospital stay longer than 10 days and death. The Mann-Whitney test was used for the comparison of mean score differences for clinical and demographic variables.
The chi-square test and multiple logistic regression models were used for the analysis of risk factors for death and length of hospital stay > 10 days. Dependent variables of the analysis were death and length of hospital stay > 10 days, and independent variables were the clinical and demographic variables analyzed. The cut-off point used for the score was 8. Also, the Hosmer-Lemeshow test was used for a better model performance.
Results
Most of the patients were females (55%), 60% had rheumatic heart valve disease, and 38% of the surgeries were reoperations (Table 1) .
Score validation
The internal consistency was good (Cronbach's Alpha = 0.65) for the score, thus showing that the parameters used to comprise the score were correlated. ROC curves were used to define the best cut-off point for the score. In relation to the ROC curve, the area under the curve was 0.64 for death (Figure 1 ) and 0.61 for length of hospital stay longer than 10 days ( Figure 2) ; the best cut-off point was 8 for both. Then, the score was divided into VMCP < 8 and VMCP �� 8.
Considering the score as a quantitative variable, a significant difference was found for the mean scores for: rheumatic fever (7.5 vs 7.8; p< 0.001), renal failure (7.6 vs 8.5; p<0.001), atrial fibrillation (7.5 vs 8.1; p<0.001), reoperation (7.5 vs 8.0; p<0.001) and death (7.6 vs 8.4; p=0.002).
Morbidity
In the univariate analysis, a significant association could be observed between length of hospital stay > 10 days and some variables (Table 3) , especially a VMCP score > 8. This association was also observed in the multivariate analysis, which showed that a VMCP score > 8 is able to predict length of hospital stay > 10 days, that is, higher morbidity. The other variables: atrial fibrillation (Odds Ratio [OR] =2.2; p=0.001), rheumatic fever (OR=1.7; p=0.005), dyslipidemia (OR=1.9; p=0.039), cigarette smoking (OR=1.8; p=0.020), and previous endocarditis (OR=2.8; p=0.024) also remained as risk factors for morbidity in the multivariate analysis (Table 4) .
Mortality
For mortality, the univariate analysis showed a statistically significant association between some variables and death (Table 5) , including the VMCP score > 8. The multivariate analysis showed a higher number of deaths related to renal failure (OR=5.6; p<0.001), reoperation (OR=2.6; p=0.004), and diabetes (OR=3.0; p=0.014) (Table 6 ). However, in the multivariate analysis the VMCP score was not statistically significant (p=0.258), showing only a small increase in the odds ratio (1.46); its 95% confidence interval passed through value 1.0. Therefore, the VMCP score > 8 cannot be considered predictive of death, but only a risk factor for higher mortality.
Discussion
Adaptive changes frequently result in a long natural history in most patients with heart valve disease 4, 5 . Throughout this history, surgery may be indicated, and is frequently fundamental for the improvement of symptoms 4 . Additionally, normal left ventricular function is essential for a better outcome of these patients 6, 7 .
In countries where rheumatic valve diseases 3 remain as a serious health problem some peculiarities have been observed in the comparison with patients with degenerative valve disease. These patients have lower mean age (50±17 years)
The routine follow-up of these patients is a good clinical practice to determine the best moment for surgery 15, 16 . Waiting for the onset of symptoms 4, 16 , preventing irreversible reduction of the left ventricular function 15 , in association with other well-established criteria defined in heart valve disease consensuses 14 help determine the right moment for surgical indication. The best moment is that in which the patient will have the best early and late prognosis.
We selected four clinical and laboratory variables to characterize a specific moment in the natural history of a group of patients with heart valve disease, thus creating the VMCP index and score.
This score proved to be an important tool to predict surgical morbidity in heart valve surgery. Simplicity and easiness of use are some of the advantages of the VMCP score. However, this score was not able to predict mortality in the multivariate analysis, perhaps because of the small sample size. This fact, however, did not reduce its value as an interesting new marker of severity. In association with other parameters, a VMCP score > 8 was observed to be related to more severely ill patients probably with worse prognosis. These patients require more intensive medical care both during hospitalization and after discharge. Thus, a VMCP score > 8 also means a more advanced natural history.
This study confirmed that the presence of comorbidities corresponded to longer length of hospital stay and higher death risk. Additionally, the presence of diabetes, renal failure and reoperation increase the death risk but not the length of hospital stay.
Atrial fibrillation, rheumatic etiology, dyslipidemia, cigarette smoking and previous endocarditis were identified as risk factors for a longer length of hospital stay. On the other hand, these comorbidities were not risk factors for death.
Studies on the EuroSCORE 12, 13 are very elegant in the analysis of possible risk factors for higher surgical morbidity and mortality. This score uses some clinical and laboratory parameters, estimating mortality rate by the final score. As was observed in this study, decreased renal function, previous endocarditis, myocardial dysfunction, pulmonary hypertension and previous cardiac surgery are also parameters of a worse prognosis in the EuroSCORE.
Some parameters such as age, high blood glucose and serum creatinine level may increase the degree of prediction of the VMCP score, but their absence does not invalidate the method and they may be used in further studies.
The VMCP index and score are, therefore, a simple and useful clinical tool and can be used in the daily clinical practice. They can identify a group at a higher surgical risk for heart valve surgery, in addition to helping define the best moment for surgical indication during the clinical follow-up of patients with heart valve disease.
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